| dbo:abstract
|
- The United States Medicare Quality Cancer Care Demonstration Act of 2009 (H.R. 2872), is a landmark national initiative intended to enhance the quality of cancer care, focused on seniors who covered by Medicare. Approximately 45% of cancer patients are Medicare beneficiaries, while also controlling costs. House bill H.R. 2872 was introduced by Congressman Artur Davis (D-AL) and cosponsored by Representatives, Steve Israel (D-NY) and Mary Jo Kilroy (D-OH). The Quality Cancer Care Demonstration (QCCD) project was developed by a community of oncologists, with inputs from policy experts, to be a national Medicare demonstration project focused on two key aspects of cancer care: treatment planning and end-of-life care. Treatment planning involves all essential components of establishing the cancer care plan and monitoring its effectiveness. End-of-life care involves all essential components of patient-centric cancer care, relating to individuals facing end-of-life planning and decision-making. By the Medicare payment system, H.R. 2872 calls for national reporting of key metrics of evidence-based care, and also refines those metrics; develops new Medicare performance-based reimbursement system that is patient-centric and quality driven, while aligning better with cost control. The bill includes the following elements:
* Establish a national Medicare demonstration project implemented by the Centers for Medicare & Medicaid Services (CMS) and is open to all oncology practices.
* Address current shortcomings in treatment planning and end-of-life care by improving metrics and aligning incentives relating to the care.
* Quality reporting measures by oncologists through the Medicare reimbursement system, concerning their treatment plans and end-of-life care. It would also include refinement and improvement of these plans.
* Allocate $300 million per year in Medicare funding to revise the Medicare payment system. Those payments would be based on quality and cost-efficiency.
* Incorporate the key elements under discussion in the healthcare reform debate — quality care delivery, evidence-based medicine, care coordination, patient-centric, cost control, health information technology, and pay-for-performance — in producing an evolved payment system.
* Evaluation of QCCD to determine the participation of oncologists and cost-effectiveness of the plan.
* Conducting of a demonstration project over a period of not less than two years to allow for improvement in reporting, metrics, and analysis.
* A substantive project that can be implemented within 6 months by CMS and will be available to all oncologists nationwide.
* Could serve as a model for other areas of specific care relating to terminal illness for Medicare beneficiaries. (en)
|
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 3568 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- The United States Medicare Quality Cancer Care Demonstration Act of 2009 (H.R. 2872), is a landmark national initiative intended to enhance the quality of cancer care, focused on seniors who covered by Medicare. Approximately 45% of cancer patients are Medicare beneficiaries, while also controlling costs. House bill H.R. 2872 was introduced by Congressman Artur Davis (D-AL) and cosponsored by Representatives, Steve Israel (D-NY) and Mary Jo Kilroy (D-OH). The bill includes the following elements: (en)
|
| rdfs:label
|
- Medicare Quality Cancer Care Demonstration Act (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
